Zoledronic acid enhances tumor growth and metastatic spread in a mouse model of jaw osteosarcoma
CONCLUSION: The use of bisphosphonates in the therapeutic strategy for JO should be further explored, as should the role of bone resorption in the pathophysiology of the disease.PMID:38376129 | DOI:10.1111/odi.14897
Source: Cancer Control - Category: Cancer & Oncology Authors: Than-Thuy Nham Romain Guiho R égis Brion J érôme Amiaud B énédicte Brounais Le Royer Anne Gomez-Brouchet Fran çoise Rédini H élios Bertin Source Type: research
More News: Bone Cancers | Cancer | Cancer & Oncology | Oral Cancer | Osteosarcoma | Reclast | Zometa